Acellular dermal matrices, also known as acellular cadaver grafts, are human-derived dermal grafts that is used as a substitute for autologous dermis in dermal reconstruction. They help restore tissue function, facilitate healing and reduce scarring. These matrices are biologically engineered scaffolds made of collagen and elastin fibers and do not contain cellular components such as fibroblasts, antigen presenting cells and structural proteins. They act as a platform for cellular repopulation and revascularization, promoting tissue regeneration.
The global acellular dermal matrices market is estimated to be valued at US$ 10.14 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the Acellular Dermal Matrices are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. These players are focusing on launching new and advanced products and strengthening their distribution networks globally.
The key opportunities in the acellular dermal matrices market include increasing use of these matrices for various plastic and reconstructive surgeries as well as burn treatments. With rising acceptance, the demand for acellular dermal matrices is expected to increase tremendously over the forecast period.
Globally, the companies are expanding their footprint by entering emerging markets in Asia Pacific, Latin America, and Middle East & Africa. Favorable government support and initiatives to promote medical tourism will drive the market growth in these regions over the coming years.
Market drivers: One of the major drivers for Acellular Dermal Matrices Market Demand is rising number of surgical procedures. According to the American Society of Plastic Surgeons, over 18 million surgical and minimally invasive cosmetic procedures were performed in the US in 2020 alone. Breast augmentations, liposuction and tummy tucks were among the top five surgical procedures.
Market restraints:
High costs associated with acellular dermal matrices is a major challenging factor hampering the market growth. These grafts require cryoprocessing to remove cellular content which makes them more expensive compared to conventional allografts. This acts as a barrier, especially in developing regions with low disposable incomes.
Segment Analysis
Acellular dermal matrices market comprises of small intestine sub mucosa, dermal matrices, and collagen matrices segments. The dermal matrices segment currently dominates other segments due to its widespread usage in plastic & reconstructive surgeries. Dermal matrices are preferred as they exhibit lower rejection rates and minimal shrinkage post-implantation. They mimic the structural and mechanical properties of human skin.
Global Analysis
North America dominates the global acellular dermal matrices market with the highest market share. This is attributed to high healthcare expenditure, funding initiatives for ADM R&D, and presence of key players in the region. Asia Pacific is expected to witness the fastest growth rate during the forecast period owing to rising income levels, increasing healthcare awareness, and growing demand for reconstructive surgeries. Rising cases of accidents and trauma in emerging economies like India and China will further drive regional market growth.
Get more insights on Acellular Dermal Matrices Market
Comments
0 comment